Importing drugs harms Americans’ safety: MacMenamin
Source: Reno Gazette Journal.
Liz MacMenamin’s editorial was published in the Reno Gazette Journal on November 1, 2017. MacMenamin is is vice president of government affairs for the Retail Association of Nevada.
Importing drugs harms Americans' safety: MacMenamin
Liz MacMenamin’s editorial was published in the Reno Gazette Journal on November 1, 2017. MacMenamin is is vice president of government affairs for the Retail Association of Nevada.
As drug prices continue to soar in the United States, many individuals see importing drugs from abroad as the best solution to overcome this problem. Bernie Sanders and John McCain have both introduced separate legislation encouraging the importation of drugs from across the border. Though this may appear as a simple and innocent fix to the problem of high drug prices, the reality is starkly different. Importation threatens the safety of all Americans and the security of the United States’ airtight pharmaceutical quality control system.
When patients order from a third party abroad, they expect to receive legitimate pills with active ingredients. In reality, many receive adulterated and unsafe counterfeits, placebos or sugar pills with the smallest, ineffective doses. Some pharmacies in the states are also unaware they may be buying dangerous and ineffective drugs, though they have the best intentions: bringing down the cost for their patients.
The United States cannot ensure from where imported drugs originate. Many drugs are imported from Canada; however, the majority of these drugs are manufactured in other countries. Once these dangerous counterfeits reach the borders of Canada, there is no quality assurance, unlike the Federal Drug Administration’s system in the U.S.
The FDA has an extremely airtight quality control system for all drugs manufactured in the United States for the market. The FDA already lacks necessary resources to ensure quality of drugs within the United States. This year, four previous FDA commissioners wrote a letter stating how it would be nearly impossible to retain an airtight quality control system on all imported drugs. They stated the FDA would no longer be able to secure all access points to the country. Even if they could, the funding would not be granted for such a possibility.
Importing drugs will also increase the potential for already illegal drugs to be more easily accessible. Fentanyl has taken over the streets of America. This drug is 50 to 100 times more deadly than heroin. A simple dusting of the drug can lead to overdose, putting our cops and first responders in higher danger.
Further, the importation of drugs from abroad is not free trade, as so many have characterized it. As Americans for Tax Reform has stated in an open letter, “implementing an importation policy is simply adopting market-distorting price controls from other countries, which would disrupt U.S. innovation of lifesaving and life-preserving medicines.” If more Americans were to purchase their drugs from abroad, fewer dollars would then be reinvested into research and development with drug companies. The loss of R & D dollars would not only hurt the potential of receiving more lifesaving drugs, but would also cause cuts across the board in the drug industry.
This legislation must not be allowed to pass Congress. Americans’ lives are dependent on the FDA’s quality assurance and these bills fly in the face of that. We cannot put our health at risk. I urge Senator Heller to actively work against this bill and ensure it never sees the House floor.